Moderna (MRNA) skyrocketed today, more than doubling, up 150 percent, on the news of a successful Phase 3 melanoma trial. The combination of Moderna's vaccine with Merck's Keytruda significantly reduced the risk of melanoma returning or spreading...

Qualcomm (QCOM) is being added to the Sound Advice portfolio. A complete explanation will follow in the next issue of Sound Advice scheduled to be published on the first of September, but we are adding QCOM now as a timely investment.

The stock...